HuGE Literature Finder
Records
1
-
30
| A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age with Cystic Fibrosis Homozygous for F508del-CFTR. American journal of respiratory and critical care medicine 2022 6 206 (10): 1239-1247. Rayment Jonathan H, Asfour Fadi, Rosenfeld Margaret, Higgins Mark, Liu Lingyun, Mascia Molly, Paz-Diaz Hildegarde, Tian Simon, Zahigian Rachel, McColley Susanna |
| CFTR heterozygosity in severe asthma with recurrent airway infections: a retrospective review. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022 6 18 (1): 46. Priel Eldar, Adatia Adil, Kjarsgaard Melanie, Nair Parameswar |
| Safety of chronic hypertonic bicarbonate inhalation in a cigarette smoke-induced airway irritation guinea pig model. BMC pulmonary medicine 2022 4 22 (1): 131. Csek? Kata, Hargitai Dóra, Draskóczi Lilla, Kéri Adrienn, Jaikumpun Pongsiri, Kerémi Beáta, Helyes Zsuzsanna, Zsembery Ák |
| SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation. Frontiers in molecular biosciences 2022 4 9 850261. Mercier Julia, Calmel Claire, Mésinèle Julie, Sutanto Erika, Merabtene Fatiha, Longchampt Elisabeth, Sage Edouard, Kicic Anthony, Boëlle Pierre-Yves, Corvol Harriet, Ruffin Manon, Guillot Lo |
| Airways glutathione S-transferase omega-1 and its A140D polymorphism are associated with severity of inflammation and respiratory dysfunction in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2021 2 20 (6): 1053-1061. Piaggi Simona, Marchi Elisabetta, Carnicelli Vittoria, Zucchi Riccardo, Griese Matthias, Hector Andreas, Sorio Claudio, Pompella Alfonso, Corti Alessand |
| Genetic Polymorphisms in the Host and COVID-19 Infection. Advances in experimental medicine and biology 2021 5 1318 109-118. Delanghe Joris R, De Buyzere Marc L, Speeckaert Marijn |
| Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis. PloS one 2020 4 15 (4): e0231285. Pineau Fanny, Caimmi Davide, Magalhães Milena, Fremy Enora, Mohamed Abdillah, Mely Laurent, Leroy Sylvie, Murris Marlène, Claustres Mireille, Chiron Raphael, De Sario Alberti |
| Delayed age at menarche in chronic respiratory diseases. European journal of clinical investigation 2020 11 51 (5): e13461. Gaudino Rossella, Dal Ben Sarah, Cavarzere Paolo, Volpi Sonia, Piona Claudia, Boner Attilio, Antoniazzi Franco, Piacentini Giorg |
| Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 5 19 (6): 1021-1026. Bampi Giovana B, Rauscher Robert, Kirchner Sebastian, Oliver Kathryn E, Bijvelds Marcel J C, Santos Leonardo A, Wagner Johannes, Frizzell Raymond A, de Jonge Hugo R, Sorscher Eric J, Ignatova Zo |
| Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis. Frontiers in genetics 2020 11 11 570403. Horn Tabea, Ludwig Michael, Eickmeier Olaf, Neerinex Anne H, Maitland-van der Zee Anke H, Smaczny Christina, Wagner Thomas O F, Schubert Ralf, Zielen Stefan, Majoor Christof, Bos Lieuwe D, Schmitt-Grohé Sabi |
| Influence of pancreatic status, CFTR mutations, Staphylococcus aureus and/or Pseudomonas aeruginosa infection/colonization on lung function in cystic fibrosis during a 2-year follow-up period. Wiener klinische Wochenschrift 2020 5 132 (19-20): 572-580. Pascoal Maíra Andrade, Marson Fernando Augusto Lima, Paschoal Ilma Aparecida, Levy Carlos Emíl |
| Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation. PloS one 2020 15 (11): e0239189. Dang Hong, Polineni Deepika, Pace Rhonda G, Stonebraker Jaclyn R, Corvol Harriet, Cutting Garry R, Drumm Mitchell L, Strug Lisa J, O'Neal Wanda K, Knowles Michael |
| Secondhand Smoke Exposure and Serum Trypsinogen in Cystic Fibrosis Carriers. Pancreas 2019 Oct 48 (9): 1155-1159. Ellery Kate M, Kopp Benjamin, Conwell Darwin L, Gariepy Cher |
| Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation. Annals of the American Thoracic Society 2019 10 17 (2): 212-220. Harris J Kirk, Wagner Brandie D, Zemanick Edith T, Robertson Charles E, Stevens Mark J, Heltshe Sonya L, Rowe Steven M, Sagel Scott |
| Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2019 12 19 (4): 608-613. Kosamo Susanna, Hisert Katherine B, Dmyterko Victoria, Nguyen Catherine, Black R Anthony, Holden Tarah D, Radella Frank, Cotten Pauline A, Goss Christopher H, Aitken Moira L, Wurfel Mark |
| Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity. American journal of respiratory and critical care medicine 2018 01 197 (1): 79-93. Polineni Deepika, Dang Hong, Gallins Paul J, Jones Lisa C, Pace Rhonda G, Stonebraker Jaclyn R, Commander Leah A, Krenicky Jeanne E, Zhou Yi-Hui, Corvol Harriet, Cutting Garry R, Drumm Mitchell L, Strug Lisa J, Boyle Michael P, Durie Peter R, Chmiel James F, Zou Fei, Wright Fred A, O'Neal Wanda K, Knowles Michael |
| Primary sclerosing cholangitis is associated with abnormalities in CFTR. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2018 5 17 (5): 666-671. Werlin Steven, Scotet Virginie, Uguen Kevin, Audrezet Marie-Pierre, Cohen Michael, Yaakov Yasmin, Safadi Rifaat, Ilan Yaron, Konikoff Fred, Galun Eitan, Mizrahi Meir, Slae Mordechai, Sayag Shirley, Cohen-Cymberknoh Malena, Wilschanski Michael, Ferec Clau |
| TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression. Journal of translational medicine 2013 Jan 11 (1): 1. Shmarina G, Pukhalsky A, Petrova N, Zakharova E, Avakian L, Kapranov N, Alioshkin V |
| Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2012 Jan 11 (1): 63-7. Corvol Harriet, Beucher Julie, Boëlle Pierre-Yves, Busson Pierre-François, Muselet-Charlier Céline, Clement Annick, Ratjen Felix, Grasemann Hartmut, Laki Judith, Palmer Colin N A, Elborn J Stuart, Mehta An |
| AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis. PloS one 2012 7 (7): e41913. Beucher Julie, Boëlle Pierre-Yves, Busson Pierre-François, Muselet-Charlier Céline, Clement Annick, Corvol Harriet, |
| Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis. BMC pulmonary medicine 2012 12 (1): 50. Marson Fernando A L, Bertuzzo Carmen S, Ribeiro Antônio F, Ribeiro José |
| Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis. Pediatric pulmonology 2011 Apr 46 (4): 385-92. Dorfman Ruslan, Taylor Chelsea, Lin Fan, Sun Lei, Sandford Andrew, Paré Peter, Berthiaume Yves, Corey Mary, Durie Peter, Zielenski Julian, |
| Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology 2011 Mar 21 (3): 271-82. Chalmers James D, Fleming Gillian B, Hill Adam T, Kilpatrick David |
| Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy. International journal of immunogenetics 2010 Jun 37 (3): 169-75. Segat L, Morgutti M, Athanasakis E, Trevisiol C, Amaddeo A, Poli F, Crovella |
| EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity. Physiological genomics 2010 Mar 41 (1): 71-7. Darrah Rebecca, McKone Edward, O'Connor Clare, Rodgers Christine, Genatossio Alan, McNamara Sharon, Gibson Ronald, Stuart Elborn J, Ennis Madeleine, Gallagher Charles G, Kalsheker Noor, Aitken Moira, Wiese Dawn, Dunn John, Smith Paul, Pace Rhonda, Londono Douglas, Goddard Katrina A B, Knowles Michael R, Drumm Mitchell |
| Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009 Apr 458 (7241): 1039-42. Gu YuanYuan, Harley Isaac T W, Henderson Lindsay B, Aronow Bruce J, Vietor Ilja, Huber Lukas A, Harley John B, Kilpatrick Jeffrey R, Langefeld Carl D, Williams Adrienne H, Jegga Anil G, Chen Jing, Wills-Karp Marsha, Arshad S Hasan, Ewart Susan L, Thio Chloe L, Flick Leah M, Filippi Marie-Dominique, Grimes H Leighton, Drumm Mitchell L, Cutting Garry R, Knowles Michael R, Karp Christopher |
| Rhinosinusitis in cystic fibrosis: not a simple story. International journal of pediatric otorhinolaryngology 2008 May 72 (5): 619-24. Babinski Dariusz, Trawinska-Bartnicka Mar |
| Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clinical chemistry 2008 Jan 54 (1): 131-8. Chang Yu-Ting, Chang Ming-Chu, Su Ta-Chen, Liang Po-Chin, Su Yi-Ning, Kuo Chun-Hung, Wei Shu-Chen, Wong Jau-M |
| The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Human genetics 2006 Apr 119 (3): 331-43. Stanke Frauke, Becker Tim, Cuppens Harry, Kumar Vinod, Cassiman Jean-Jacques, Jansen Silke, Radojkovic Dragica, Siebert Benny, Yarden Jennifer, Ussery David W, Wienker Thomas F, Tümmler Burkha |
| Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis. Archivum immunologiae et therapiae experimentalis 0 54 (4): 271-6. Urquhart Donald S, Allen Jennifer, Elrayess Mohamed, Fidler Katy, Klein Nigel, Jaffé Ad |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: